Therefore, enhanced AMPK activation caused by increased STIM1 expression could activate more PFK-1 to elevate glycolysis in cardiac hypertrophy (Figure 4➃), while the case is another way around in diabetic cardiomyopathy. Here, STIM1 is linked to diabetic cardiomyopathy.